Arcturus Therapeutics Holdings Inc. (ARCT) Social Stream



Arcturus Therapeutics Holdings Inc. (ARCT): $39.89

3.88 (+10.77%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Arcturus Therapeutics Holdings Inc (ARCT) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Arcturus Therapeutics Holdings Inc.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
11 $140 $25 $73.3 $37.79 93.97%
10 $140 $27 $78 $37.79 106.4%
11 $140 $27 $73.9 $37.79 95.55%
10 $140 $27 $77.111 $37.79 104.05%

The Trend in the Analyst Price Target


ARCT's average price target has moved down $16.79 over the prior 49 weeks.

ARCT reports an average of 85.14% for its upside potential over the past 18 months.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-16 10 140 27 78.00 37.36 108.78%
2021-08-05 14 160 23 80.36 53.93 49.01%
2021-04-03 9 160 31 86.15 40.50 112.72%
2020-12-19 11 172 18 99.86 99.29 0.57%
2020-06-08 8 69 18 51.00 NA NA%

ARCT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.8 5 0 1 4 4 10

The Trend in the Broker Recommendations


Over the past 153 days, ARCT's average broker recommendation rating worsened by 0.42.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ARCT as an investment opportunity.

  • Arcturus Therapeutics Holdings Inc's variance in analysts' estimates is less than -295.98% of all US stocks.
  • Arcturus Therapeutics Holdings Inc's number of analysts covering the stock is higher than 397.9% of stocks in the small market cap category.
  • The average analyst price target of ARCT is greater than 384.26% of stocks in the small market cap category.
  • Arcturus Therapeutics Holdings Inc's upside potential (average analyst target price relative to current price) is higher than 328.37% of all US stocks.

In the Pharmaceutical Products industry, KLDO, ACB and EDIT are the three stocks most similar to Arcturus Therapeutics Holdings Inc regarding the price target and analyst recommendation information presented here.

Is ARCT a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6923 seconds.